EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure

June Hwa Bae iD, Jung-Bin Park iD, Ji Eun Baek iD, Seung Wook Hong iD, Sang Hyoung Park iD, Dong-Hoon Yang iD, Byong Duk Ye iD, Jeong-Sik Byeon iD, Seung-Jae Myung iD, Suk-Kyun Yang iD, Sung Wook Hwang iD

Gut and Liver · 2024

DOI: 10.5009/gnl230291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gut and Liver, 2024. Verfasst von June Hwa Bae und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Infliximab, Drug Substitution, Treatment Failure. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeInfliximabDrug SubstitutionTreatment FailureGastrointestinal AgentsHumansFemaleMaleRetrospective StudiesMiddle AgedAdultInjections, SubcutaneousAdministration, IntravenousLeukocyte L1 Antigen ComplexC-Reactive ProteinFecesTreatment Outcome

Stichwörter der Autor:innen

InfliximabSubcutaneousUlcerative colitis

Substanzen

InfliximabGastrointestinal AgentsLeukocyte L1 Antigen ComplexC-Reactive Protein

Autor:innen und Institutionen

  • Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

ORCID-Profile: June Hwa Bae, Jung-Bin Park, Ji Eun Baek, Seung Wook Hong, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sung Wook Hwang

Förderung

  • National Research Foundation of Korea
  • Ministry of Education

Zitieren

APA

Bae, J. H., Park, J. B., Baek, J. E., Hong, S. W., Park, S. H., Yang, D. H., Ye, B. D., Byeon, J. S., Myung, S. J., Yang, S. K., & Hwang, S. W. (2024). Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure. Gut and Liver. https://doi.org/10.5009/gnl230291

Vancouver

Bae JH, Park JB, Baek JE, Hong SW, Park SH, Yang DH, et al. Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure. Gut and Liver. 2024. doi:10.5009/gnl230291

BibTeX
@article{Bae2024,
  author = {Bae, June Hwa and Park, Jung-Bin and Baek, Ji Eun and Hong, Seung Wook and Park, Sang Hyoung and Yang, Dong-Hoon and Ye, Byong Duk and Byeon, Jeong-Sik and Myung, Seung-Jae and Yang, Suk-Kyun and Hwang, Sung Wook},
  title = {Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure},
  journal = {Gut and Liver},
  year = {2024},
  doi = {10.5009/gnl230291}
}
Kostenlos starten →